G622 | ±âŸ µ¶¼º ¹°Áú¿¡ ÀÇÇÑ ´Ù¹ß½Å°æº´Áõ | Polyneuropathy due to other toxic agents |
 |
G628 | ±âŸ ¸í½ÃµÈ ´Ù¹ß½Å°æº´Áõ | Other specified polyneuropathies |
 |
G628 | ¹æ»ç¼±-À¯¹ß ´Ù¹ß½Å°æº´Áõ | Radiation-induced polyneuropathy |
 |
G629 | »ó¼¼ºÒ¸íÀÇ ´Ù¹ß½Å°æº´Áõ | Polyneuropathy, unspecified |
 |
G629 | ½Å°æº´Áõ NOS | Neuropathy NOS |
 |
G63 | ´Þ¸® ºÐ·ùµÈ Áúȯ¿¡¼ÀÇ ´Ù¹ß½Å°æº´Áõ | Polyneuropathy in diseases classified elsewhere |
 |
G630 | ´Þ¸® ºÐ·ùµÈ °¨¿°¼º ¹× ±â»ýÃæ¼º Áúȯ¿¡¼ÀÇ ´Ù¹ß½Å°æº´Áõ | Polyneuropathy in infectious and parasitic diseases classified elsewhere |
 |
G630 | µðÇÁÅ׸®¾Æ¿¡¼ÀÇ ´Ù¹ß½Å°æº´Áõ | Polyneupathy in diphtheria (A36.8+) |
 |
G630 | Àü¿°¼º ´ÜÇÙ±¸Áõ¿¡¼ÀÇ ´Ù¹ß½Å°æº´Áõ | Polyneupathy in infectious mononucleosis(B27.-+) |
 |
G630 | ³ªº´¿¡¼ÀÇ ´Ù¹ß½Å°æº´Áõ | Polyneupathy in leprosy(A30.-+) |
 |
G630 | ¶óÀÓº´¿¡¼ÀÇ ´Ù¹ß½Å°æº´Áõ | Polyneupathy in Lyme disease (A69.2+) |
 |
G630 | º¼°Å¸®¿¡¼ÀÇ ´Ù¹ß½Å°æº´Áõ | Polyneupathy in mumps (B26.8+) |
 |
G630 | Æ÷ÁøÈÄ¿¡¼ÀÇ ´Ù¹ß½Å°æº´Áõ | Postherpetic polyneupathy (B02.2+) |
 |
G630 | ¸¸±â¸Åµ¶¿¡¼ÀÇ ´Ù¹ß½Å°æº´Áõ | Polyneupathy in syphilis, late (A52.1+) |
 |
G630 | ¸¸±â¼±Ãµ¸Åµ¶¿¡¼ÀÇ ´Ù¹ß½Å°æº´Áõ | Polyneupathy in congenital sypyilis, late(A50.4+) |
 |
G630 | °áÇÙ¿¡¼ÀÇ ´Ù¹ß½Å°æº´Áõ | Polyneupathy in tuberculous (A17.8+) |
 |
G631 | ½Å»ý¹°¼º Áúȯ¿¡¼ÀÇ ´Ù¹ß½Å°æº´Áõ | Polyneuropathy in neoplastic disease(C00-D48+) |
 |
G632 | ´ç´¢º´¼º ´Ù¹ß½Å°æº´Áõ (4´ÜÀ§ ¼ýÀÚ .4¿¡ ÇØ´çÇÏ´Â E10-E14+) | Diabetic polyneuropathy(E10-E14+ ¿¡¼ .4) |
 |
G633 | ±âŸ ³»ºÐºñ ¹× ´ë»ç¼º Áúȯ¿¡¼ÀÇ ´Ù¹ß½Å°æº´Áõ | Polyneuropathy in other endocrine and metabolic diseases(E00-E07+, E15-E16+, E20-E34+, E70-E89+) |
 |
G634 | ¿µ¾ç°áÇÌ¿¡¼ÀÇ ´Ù¹ß½Å°æº´Áõ | Polyneuropathy in nutritional deficiency (E40-E64+) |
 |